Ultragenyx Pharmaceutical Inc.RARENASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
23.76%
↑ 189% above average
Average (9y)
-26.71%
Historical baseline
Range
High:56.88%
Low:-118.24%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 23.76% |
| 2023 | 18.48% |
| 2022 | -51.04% |
| 2021 | -118.24% |
| 2020 | 56.88% |
| 2019 | -79.35% |
| 2018 | 44.24% |
| 2017 | -14.65% |
| 2016 | -56.82% |
| 2015 | -90.38% |